Epigenetic regulation in fibrosis progress
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 173, 105910
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81873580)
- Sichuan University (2019HXCX05)
- West China Hospital, Sichuan University
This publication has 260 references indexed in Scilit:
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiationHepatology, 2012
- MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in ratsToxicology, 2011
- Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent contextNucleic Acids Research, 2011
- Essential Role of MeCP2 in the Regulation of Myofibroblast Differentiation during Pulmonary FibrosisThe American Journal of Pathology, 2011
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2010
- MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and FibrosisGastroenterology, 2010
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- Lineage-Specific Polycomb Targets and De Novo DNA Methylation Define Restriction and Potential of Neuronal ProgenitorsMolecular Cell, 2008